{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:17Z","timestamp":1787032877327,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,18]]},"DOI":"10.7759\/cureus.37747","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:43:04Z","timestamp":1681792984000},"source":"Crossref","is-referenced-by-count":6,"title":["Intracranial Hemorrhage After Pfizer-BioNTech (BNT162b2) mRNA COVID-19 Vaccination: A Case Report"],"prefix":"10.7759","author":[{"given":"Kivanc","family":"Yangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doga D","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajlan","family":"Uzunkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060576","article-title":"Pancreatic injury after COVID-19 vaccine-a case report","volume":"9","author":"Cie\u015blewicz A","year":"2021","unstructured":"Cie\u015blewicz A, Dudek M, Krela-Ka\u017amierczak I, Jab\u0142ecka A, Lesiak M, Korzeniowska K. Pancreatic injury after COVID-19 vaccine-a case report. Vaccines (Basel). 2021, 9:10.3390\/vaccines9060576","journal-title":"Vaccines (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23526","article-title":"Pfizer-BioNTech COVID-19 vaccine (BNT162b2) side effects: a systematic review","volume":"14","author":"Dighriri IM","year":"2022","unstructured":"Dighriri IM, Alhusayni KM, Mobarki AY, et al.. Pfizer-BioNTech COVID-19 vaccine (BNT162b2) side effects: a systematic review. Cureus. 2022, 14:e23526. 10.7759\/cureus.23526","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030362","article-title":"Intracranial hemorrhage due to potential rupture of an arteriovenous malformation after BNT162b2 COVID-19 mRNA vaccination in a young Korean woman: case report","volume":"10","author":"Kim BH","year":"2022","unstructured":"Kim BH, Yoo MC. Intracranial hemorrhage due to potential rupture of an arteriovenous malformation after BNT162b2 COVID-19 mRNA vaccination in a young Korean woman: case report. Vaccines (Basel). 2022, 10:10.3390\/vaccines10030362","journal-title":"Vaccines (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00186-7","article-title":"Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis","volume":"3","author":"Rubbert-Roth A","year":"2021","unstructured":"Rubbert-Roth A, Vuilleumier N, Ludewig B, Schmiedeberg K, Haller C, von Kempis J. Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis. Lancet Rheumatol. 2021, 3:e470-2. 10.1016\/S2665-9913(21)00186-7","journal-title":"Lancet Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.06.005","article-title":"Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series","volume":"88","author":"Benger M","year":"2020","unstructured":"Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series. Brain Behav Immun. 2020, 88:940-4. 10.1016\/j.bbi.2020.06.005","journal-title":"Brain Behav Immun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-021-00326-7","article-title":"Potential\u00a0adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)","volume":"14","author":"Shimazawa R","year":"2021","unstructured":"Shimazawa R, Ikeda M. Potential\u00a0adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech). J Pharm Policy Pract. 2021, 14:46. 10.1186\/s40545-021-00326-7","journal-title":"J Pharm Policy Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.25259\/SNI_1144_2021","article-title":"Intracranial aneurysm rupture within three days after receiving mRNA anti-COVID-19 vaccination: Three case reports","volume":"13","author":"Oshida S","year":"2022","unstructured":"Oshida S, Akamatsu Y, Matsumoto Y, et al.. Intracranial aneurysm rupture within three days after receiving mRNA anti-COVID-19 vaccination: Three case reports. Surg Neurol Int. 2022, 13:117. 10.25259\/SNI_1144_2021","journal-title":"Surg Neurol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2176\/jns-nmc.2022-0012","article-title":"Rupture of Vertebral Artery Dissecting Aneurysm after mRNA Anti-COVID-19 Vaccination: A Report of Two Cases","volume":"9","author":"Chida K","year":"2022","unstructured":"Chida K, Takahashi T, Igarashi S, et al.. Rupture of Vertebral Artery Dissecting Aneurysm after mRNA Anti-COVID-19 Vaccination: A Report of Two Cases. NMC Case Rep J. 2022, 9:95-100. 10.2176\/jns-nmc.2022-0012","journal-title":"NMC Case Rep J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000140636.30204.da","article-title":"Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases","volume":"35","author":"Fr\u00f6sen J","year":"2004","unstructured":"Fr\u00f6sen J, Piippo A, Paetau A, Kangasniemi M, Niemel\u00e4 M, Hernesniemi J, J\u00e4\u00e4skel\u00e4inen J. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke. 2004, 35:2287-93. 10.1161\/01.STR.0000140636.30204.da","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00012-6","article-title":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study","volume":"3","author":"Cavalli G","year":"2021","unstructured":"Cavalli G, Larcher A, Tomelleri A, et al.. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021, 3:e253-61. 10.1016\/S2665-9913(21)00012-6","journal-title":"Lancet Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021, 144:471-84. 10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023862","article-title":"Subarachnoid hemorrhage and COVID-19: association or coincidence?","volume":"99","author":"Cezar-Junior AB","year":"2020","unstructured":"Cezar-Junior AB, Faquini IV, Silva JL, et al.. Subarachnoid hemorrhage and COVID-19: association or coincidence?. Medicine (Baltimore). 2020, 99:e23862. 10.1097\/MD.0000000000023862","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-021-05038-0","article-title":"Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report","volume":"164","author":"Takeyama R","year":"2022","unstructured":"Takeyama R, Fukuda K, Kouzaki Y, Koga T, Hayashi S, Ohtani H, Inoue T. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta Neurochir (Wien). 2022, 164:543-7. 10.1007\/s00701-021-05038-0","journal-title":"Acta Neurochir (Wien)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases","volume":"85","author":"McMahon DE","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, et al.. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021, 85:46-55. 10.1016\/j.jaad.2021.03.092","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee EJ","year":"2021","unstructured":"Lee EJ, Cines DB, Gernsheimer T, et al.. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021, 96:534-7. 10.1002\/ajh.26132","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/147265-intracranial-hemorrhage-after-pfizer-biontech-bnt162b2-mrna-covid-19-vaccination-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:55:47Z","timestamp":1707490547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/147265-intracranial-hemorrhage-after-pfizer-biontech-bnt162b2-mrna-covid-19-vaccination-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.37747","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}